GLP-1s Medications 101

GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population in the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...

July 25, 23

Diabetes care: holistic solutions to improve outcomes and address individual needs

July 17, 23

Clinically Speaking: Cardiodiabesity 101

More than half of U.S. adults suffer from cardiovascular disease, diabetes or obesity and a growing number experience all three. Plan sponsors can take action to address this increasingly complex chal...

Christine Gilroy, MD, MSPH, July 13, 23

Three of the biggest drivers of health care costs

Obesity, diabetes, and cardiovascular disease are on the rise. Left unmanaged, these comorbid conditions can cause medical expenses to skyrocket and lead to poor health outcomes, inclusive of disabili...

June 07, 23

Continuous glucose monitors and why you need them

Making Continuous Glucose Monitors available to members can improve health outcomes and decrease the total cost of care.

Christine Gilroy, MD, MSPH, September 06, 22

A Step Forward in Comprehensive Diabetes Management

How our expanded Diabetes Care Value program will help to support people living with diabetes and protect against the economic costs to patients and plan sponsors.

August 31, 22